How to Read Peptide Lab Test Results: HPLC & Mass Spec Explained

Peptide lab test results answer 2 questions: how pure is this peptide (HPLC), and is it the correct peptide (Mass Spectrometry). As of March 2026, Peptigrity publishes independent HPLC purity tests from third-party laboratories (currently 600+ tests across 131 shops and 44 peptides—growing daily). This guide teaches you how to interpret every data point on those results.

Understanding lab test data is not optional for peptide buyers. A peer-reviewed study published in Pharmaceutical Research titled “Reference Standards to Support Quality of Synthetic Peptide Therapeutics” describes how USP establishes peptide quality through multiple orthogonal analytical techniques—HPLC for purity, mass spectrometry for identity, and amino acid analysis for composition. These are the same methods that produce the data you see on Peptigrity’s lab test entries and on any legitimate Certificate of Analysis. Whether you are evaluating BPC-157, semaglutide, tirzepatide, or retatrutide, the analytical principles are identical.

This article is the root of Peptigrity’s Lab Testing cluster. For deeper coverage of individual topics, see What Is HPLC Testing and Why It Matters for Peptide Purity, Peptide Purity Standards: What Percentage Is Acceptable?, and Red Flags in Peptide Certificates of Analysis. For the broader buyer verification framework, start with How to Verify Peptide Quality Before You Buy.

What Are the 2 Core Analytical Methods for Peptide Testing?

HPLC measures purity (how much of the sample is the target peptide) and Mass Spectrometry confirms identity (is this the correct compound). Both are necessary because they answer fundamentally different questions. A peptide can show 99% HPLC purity while being the wrong molecule entirely—a deletion sequence missing 1 amino acid may co-elute with the target peptide on the chromatographic column, appearing pure by HPLC while having incorrect identity.

The USP characterisation approach for peptide reference standards confirms this complementarity. As documented in the study “Reference Standards to Support Quality of Synthetic Peptide Therapeutics” (PMC10338602), multiple orthogonal techniques are required: HPLC for purity assessment, mass spectrometry for identity confirmation, and amino acid analysis for compositional verification. No single method is sufficient on its own.

On Peptigrity, every lab test entry displays at minimum the HPLC purity percentage. Some entries include mass spectrometry data in the Certificate of Analysis image. The HPLC purity value carries 60% weight in Peptigrity’s trust score formula—reflecting how central this metric is to vendor quality assessment. See how trust scores are calculated for the full methodology.

How Does HPLC Measure Peptide Purity?

HPLC (High-Performance Liquid Chromatography) measures purity by separating compounds in a sample through a chromatographic column and calculating the proportion of the target peptide relative to all detected impurities.

The standard method for peptide analysis is reverse-phase HPLC (RP-HPLC). The process works in 4 steps: the peptide sample is dissolved and injected into a column packed with a hydrophobic stationary phase (typically C18-bonded silica), a gradient of water and acetonitrile pushes compounds through the column at different rates based on their hydrophobicity, a UV detector (set to 214 nm or 220 nm—wavelengths absorbed by peptide bonds) records each compound as it exits the column, and software integrates the area under each peak to calculate purity.

The separation works because different peptides and impurities have different levels of hydrophobicity. More hydrophobic compounds interact more strongly with the C18 column and take longer to elute. This produces a unique retention time (measured in minutes) for each compound—the time at which it exits the column and reaches the detector. If 2 compounds have very similar hydrophobicity, they may co-elute (exit at the same time), which can mask impurities in the main peak. This is one reason why HPLC purity alone cannot guarantee identity—mass spectrometry is needed as the complementary method.

The output is a chromatogram—a graph showing peaks that represent individual compounds. The main peak corresponds to the target peptide. Minor peaks represent impurities: synthesis byproducts, deletion sequences (truncated peptides from incomplete amino acid coupling), oxidised residues (methionine, cysteine, tryptophan), deamidated forms (asparagine, glutamine), and other degradation products.

Purity is calculated as: main peak area ÷ total peak area × 100 = purity percentage. A result of 98.5% means 98.5% of the UV-absorbing material in the sample is the target peptide; the remaining 1.5% consists of peptide-related impurities.

The review “Related impurities in peptide medicines” published in the International Journal of Pharmaceutics provides a comprehensive catalogue of these impurities: deletion peptides from incomplete Fmoc-deprotection, diastereomeric impurities from amino acid racemisation, counter-ion contamination from trifluoroacetic acid (TFA), and cross-contamination with unrelated peptides from shared synthesis equipment.

What HPLC Does Not Measure

HPLC purity reflects only UV-absorbing organic impurities. It does not detect non-peptide contaminants: water content, residual salts, TFA counter-ions, residual solvents from manufacturing, heavy metals (lead, mercury, arsenic, cadmium), or bacterial endotoxins. A sample can show 99% HPLC purity while containing significant non-peptide contamination. This distinction is critical for understanding what the purity percentage on Peptigrity’s lab tests does and does not tell you.

The real-world consequences of undetected contamination are documented by enforcement operations. INTERPOL’s Operation Pangea XVII (December 2024–May 2025) seized 50.4 million doses of illicit pharmaceuticals across 90 countries, with peptide supplements specifically flagged as an emerging category. Many seized products would have appeared “pure” by HPLC alone—the contamination issues (non-sterile manufacturing, heavy metals, bacterial endotoxins) are invisible to chromatographic analysis.

How Do You Read an HPLC Chromatogram?

A chromatogram is a graph with retention time (minutes) on the X-axis and UV absorbance (mAU) on the Y-axis. Each peak represents a compound that absorbed UV light as it exited the chromatographic column.

A high-quality chromatogram shows 4 characteristics: a single dominant peak (the target peptide), a stable flat baseline before and after the main peak (low detector noise), minimal secondary peaks (low impurity content), and sharp peak shape without excessive tailing or fronting (good column performance and sample integrity).

What to look for in practice:

•      Single dominant peak with >95% of total area = clean, high-purity peptide. This is what you want to see.

•      Multiple significant peaks = impurities, degradation products, or potentially a mixed/wrong compound. The more peaks, the more concerning.

•      Broad, poorly resolved main peak = possible co-elution of the target peptide with a closely related impurity (such as a deletion sequence). Mass spectrometry is needed to confirm identity.

•      Elevated baseline or drifting baseline = potential method issues or very high impurity levels. Results may be unreliable.

Some CoA images on Peptigrity’s lab tests include the raw chromatogram. When reviewing these, focus on the main peak’s relative size compared to any secondary peaks. A purity percentage without the actual chromatogram is a number without verifiable context—the graphical data is the evidence.

Retention time consistency is also informative. If you compare 2 CoAs from the same vendor for the same peptide, the main peak should appear at approximately the same retention time (within ±0.5 minutes, depending on the method). A significant shift in retention time between batches suggests either a different compound, a method change, or degradation. This level of comparison becomes possible when a vendor has multiple lab tests published on Peptigrity—you can visually compare chromatograms across batches.

What Do Different Purity Percentages Mean?

Purity percentages fall into 3 practical quality tiers for research-grade peptides.

Research-grade peptides rarely achieve consistent >99% purity across an entire product catalogue. Blanket “>99% on everything” claims from a vendor warrant scrutiny—verify against independent lab tests on peptigrity.com/lab-tests. Real-world purity ranges from Peptigrity’s database: BPC-157 typically tests at 97–99.5%, semaglutide at 98–99.8%, retatrutide at 95–99%.

The peer-reviewed study “Peptide Impurities in Commercial Synthetic Peptides and Their Implications for Vaccine Trial Assessment” (PMC2238048) demonstrated that contamination at levels as low as 1% of total peptide weight produced measurable biological effects in T-cell assays—confirming that even small impurity levels can affect outcomes. Dr. Paul Knoepfler, a cell and molecular biologist at UC Davis, has publicly warned that research-grade peptides from unregulated sources carry impurity risks that pharmaceutical-grade manufacturing controls are designed to prevent.

The verification decision flow for interpreting purity percentages is: (1) check the HPLC purity percentage on the CoA or on Peptigrity’s lab tests—is it above 95%? (2) Confirm identity via mass spectrometry data—does the observed molecular weight match the theoretical mass? (3) Check the stated vs actual quantity—does the vial contain the labelled amount? If any of these 3 checks fails, the product does not meet research-grade quality standards.

How Does Mass Spectrometry Confirm Peptide Identity?

Mass spectrometry (MS) measures the molecular weight of a compound and compares it to the theoretical mass calculated from the amino acid sequence. A match within ±1 Dalton (Da) confirms the peptide is the correct molecule. A significant discrepancy indicates a wrong compound, a deletion sequence, or degradation.

The 2 most common MS variants for peptide analysis are MALDI-TOF (Matrix-Assisted Laser Desorption Ionisation — Time of Flight) and ESI-MS (Electrospray Ionisation Mass Spectrometry). Both produce a mass spectrum: a graph with mass-to-charge ratio (m/z) on the X-axis and signal intensity on the Y-axis. The dominant peak (molecular ion peak) shows the observed molecular weight.

MALDI-TOF works by embedding the peptide sample in a crystalline matrix, then firing a laser to ionise the peptide molecules. The ionised peptides fly through a vacuum tube and reach a detector—lighter molecules arrive faster than heavier ones, producing a mass spectrum. MALDI-TOF is fast, handles a wide mass range (suitable for peptides from 500 Da to over 50,000 Da), and is tolerant of sample impurities. ESI-MS works by spraying the peptide solution through a charged needle, producing multiply-charged droplets that evaporate to yield gas-phase ions. ESI produces multiple charge states for larger peptides—for example, semaglutide (~4,114 Da) appears as [M+3H]³⁺, [M+4H]⁴⁺, etc. This is normal and expected.

For practical identity verification, the key comparison is: observed molecular weight vs theoretical molecular weight. If the observed mass matches the calculated mass from the amino acid sequence within ±1 Da, identity is confirmed. A discrepancy of 100+ Da suggests a deletion sequence (missing amino acid), addition (modification), or an entirely different compound.

Why HPLC alone is insufficient: a deletion sequence—a peptide missing 1 or more amino acids from a synthesis error—may have similar chromatographic properties to the full-length target peptide. It can co-elute on the HPLC column, showing high purity by chromatographic separation. Only mass spectrometry detects the mass difference. As the PMC study on peptide recommendations for mass spectrometry-based assays states, “mass spectrometry using either ESI or MALDI is essential for the identification of desired products and mass impurities.”

On Peptigrity, lab test entries that include CoA images with mass spectrometry data provide the strongest verification—they confirm both purity (HPLC) and identity (MS). When evaluating a vendor, prioritise those with MS-confirmed lab tests.

You can verify expected molecular weights for any peptide using NIH PubChem—search the peptide name to find its theoretical molecular weight, then compare against the MS data on the CoA.

What Is the Difference Between Purity and Net Peptide Content?

This is the most critical disambiguation in peptide testing. HPLC purity and net peptide content (NPC) are 2 independent measurements that answer different questions.

HPLC purity = proportion of target peptide vs peptide-type impurities (UV-absorbing organic compounds). NPC = proportion of actual active peptide vs total vial weight (including water, salts, TFA counter-ions, and residual solvents). A peptide can be 99% HPLC pure yet only 70–85% net peptide content.

Practical dosing example: a vial labelled 5 mg with 99% HPLC purity but 75% NPC contains approximately 3.75 mg of active peptide—not 5 mg. Assuming 5 mg based on the label leads to a 25% dosing error.

TFA (trifluoroacetic acid) is the primary contributor to the NPC gap. TFA is used as a counter-ion during HPLC purification in solid-phase peptide synthesis (SPPS). It remains bound to the lyophilised peptide as a TFA salt and contributes significant mass that is not active peptide. For shorter peptides (5–15 amino acids), TFA can account for 15–25% of total vial weight. For longer peptides (30+ amino acids), the TFA proportion is lower but still meaningful. The “Related impurities in peptide medicines” review (International Journal of Pharmaceutics) confirms that TFA counter-ions originating from SPPS and purification treatments are routinely present in final peptide products.

Water content is the second contributor. Lyophilisation (freeze-drying) removes most water, but residual moisture of 2–8% is common even in well-manufactured peptides. Residual salts and solvents from the synthesis process add additional mass. The combined effect: a vial containing 5 mg of lyophilised powder by weight may contain only 3.5–4.25 mg of active peptide—even at 99% HPLC purity.

On Peptigrity, the stated vs actual quantity field on each lab test entry reveals this discrepancy. A lab test showing a 10 mg label with 7.8 mg actual content indicates a 22% gap—driven by NPC, underdosing, or both. This is one of the most common quality failures documented across Peptigrity’s lab test database.

What Additional Tests Go Beyond HPLC and Mass Spec?

HPLC and mass spectrometry address purity and identity. 4 additional tests address safety and composition—critical for injectable peptides.

Endotoxin Testing (LAL Assay)

The Limulus Amebocyte Lysate (LAL) assay detects bacterial endotoxins (lipopolysaccharides from gram-negative bacteria). Endotoxins cause fever, inflammatory responses, and in severe cases, sepsis. The FDA’s Bacterial Endotoxins/Pyrogens guidance sets the threshold pyrogenic dose at 5 EU/kg body weight for parenteral products. Results are reported as EU/mg (endotoxin units per milligram). A value below 0.5 EU/mg is desirable for injectable research peptides. Some labs on peptigrity.com/testing-labs—including Liquilabs and MZ Biolabs—offer endotoxin testing alongside HPLC.

Heavy Metal Testing (ICP-MS)

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) screens for lead, mercury, arsenic, and cadmium—manufacturing contaminants that accumulate in tissue over time. Heavy metals are invisible to HPLC and standard mass spectrometry.

Amino Acid Analysis (AAA)

AAA hydrolyses the peptide into individual amino acids and quantifies their ratios. This confirms the compositional identity beyond molecular weight—useful when 2 peptides share similar masses but different sequences. AAA also provides the most accurate measurement of net peptide content.

Residual Solvent and Sterility Testing

Residual solvent testing (GC headspace analysis) detects leftover manufacturing solvents (DMF, DCM, TFA, acetonitrile). Sterility testing confirms the absence of microbial contamination. Both are rare on research-grade CoAs but add significant safety assurance for injectable products.

How Can You Spot a Fabricated or Misleading Lab Test?

Fabricated lab tests share 6 common red flags that are detectable by informed buyers.

1.    Perfectly rounded purity numbers. Real analytical results contain decimal variation. A CoA showing exactly “99.00%” on every batch is statistically implausible—legitimate results look like 98.47%, 99.12%, 97.83%.

2.    Text-only results with no chromatogram. A purity percentage without the underlying HPLC trace is a number without evidence. Legitimate labs always include the raw chromatographic data.

3.    Identical CoAs across different peptides or lots. Every batch should produce unique analytical data. A single CoA reused across multiple products indicates fabrication.

4.    Lot number mismatch. The batch/lot number on the CoA must match the label on the physical vial. A mismatch breaks the chain of custody.

5.    Unnamed or unverifiable testing lab. Legitimate third-party labs such as those listed on peptigrity.com/testing-labs provide verification systems—QR codes, database lookups, or report IDs confirmable on the lab’s server.

6.    Very old test dates. A CoA dated 18 months ago for a product sold as “freshly synthesised” raises questions about storage conditions and degradation.

The most effective cross-verification: check peptigrity.com/lab-tests for independent results on the same vendor and peptide. If the vendor claims 99% purity but independent HPLC tests on Peptigrity show 88–92%, the vendor’s CoA is unreliable. For a deeper guide on CoA fraud patterns, see Red Flags in Peptide Certificates of Analysis.

Where Can You Get Peptides Tested Independently?

Peptigrity’s testing labs directory lists 9 independent laboratories that accept peptide samples for analysis.

The testing labs directory includes: Janoshik Analytical (Czech Republic)—HPLC + identity testing, widely referenced in the peptide community, 118 tests processed on Peptigrity. Freedom Diagnostics (USA)—130 tests processed. Vanguard Laboratory (USA)—108 tests processed. Chromate (USA)—HPLC + LC-MS with QR-code CoA verification. MZ Biolabs (USA)—DEA-licensed, QTOF-MS. Liquilabs (Czech Republic)—endotoxin, bioburden, and heavy metals alongside HPLC. Lab4Tox (Poland), peptidetest (USA), and Trust Pointe Analytics (USA).

Cost: basic HPLC purity testing costs approximately €40–€100 per sample with 5–10 business day turnaround. Full panel testing (HPLC, MS, endotoxin, quantity verification) ranges from €80–€150. For the complete step-by-step submission guide, see how to test peptides independently.

As Dr. William Seeds, President of the International Peptide Society, has emphasised in clinical peptide therapy protocols, independent third-party testing is the only method that eliminates the conflict of interest inherent in vendor self-testing. Dr. Eric Topol (Scripps Research) has provided a balanced critical analysis of the peptide industry in his review “The Peptide Craze,” noting that the evidence base for most non-FDA-approved peptides remains limited—making independent quality verification even more essential when the compound itself is not fully characterised in human studies.

After receiving results, submit your lab test to Peptigrity. Community-submitted lab tests are the foundation of the platform’s trust verification system—every submission directly contributes to vendor trust scores and helps other buyers make informed decisions.

How Does Peptigrity Use Lab Test Data in Trust Scores?

HPLC purity average across all independent tests for a shop constitutes 60% of Peptigrity’s trust score (0–5 scale). Community review average constitutes the remaining 40%.

The data you have just learned to interpret is directly powering the trust scores on peptigrity.com/shops. When you see a shop with a trust score of 4.9 and ✓ Lab Verified (49 tests), the 60% purity component reflects the average of 49 independently submitted HPLC purity results—each one following the analytical methodology described in this article.

3 weight configurations apply based on data availability: shops with both reviews and lab tests use the 40/60 split (✓ Lab Verified). Shops with reviews only use 100% review weight (⚠ Reviews Only). Shops with lab tests only use 100% purity weight. The ✓ Lab Verified badge indicates the strongest verification level because the trust score reflects both objective analytical data and subjective buyer experience.

Key safeguards: Peptigrity only accepts lab tests from independent third-party laboratories—in-house vendor testing is excluded. All results are published transparently regardless of outcome (low purity is not hidden). Scores auto-recalculate when new data is published. No shop can pay to modify its score. For the complete scoring methodology, see how we calculate trust scores. For scam-specific warning signs, see How to Spot a Scam Peptide Shop: Warning Signs & Red Flags.

The practical implication: when you see a shop with a trust score of 4.9 and ✓ Lab Verified (49 tests), you now understand that the 60% purity component reflects 49 independent HPLC analyses—each producing a chromatogram, a purity percentage calculated from peak area integration, and (in many cases) mass spectrometry confirmation. The trust score is not an abstract number; it is the mathematical output of the analytical data described in this article. For the actionable buyer verification checklist, see What to Look for in a Peptide Shop: A Buyer’s Checklist.

Conclusion

Peptide lab test results are not decorative—they are the primary evidence of product quality in an unregulated market. HPLC measures purity, mass spectrometry confirms identity, and the combination determines whether the compound in a vial matches its label.

The main benefit of understanding these methods is that it makes Peptigrity’s lab test database actionable. Instead of seeing “98.7% purity” as an abstract number, you now understand what it measures, what it misses, and how it fits into the trust score formula that powers vendor rankings.

The main limitation is that HPLC and MS do not test for every possible contaminant—endotoxins, heavy metals, and residual solvents require separate analyses. A high purity percentage does not guarantee safety for injectable use in an unregulated market.

The 3 key takeaways: always require both HPLC purity data and mass spectrometry identity confirmation (a purity number without identity verification is incomplete), understand that HPLC purity ≠ net peptide content (a 99% pure peptide may contain only 70–85% active compound by weight), and use Peptigrity’s lab test database to cross-verify vendor claims against independent data. Browse verified peptide shops ranked by trust score, or contribute to the database by submitting your own lab test results.

This article is the foundation of Peptigrity’s Lab Testing cluster. For deeper coverage, continue to: What Is HPLC Testing and Why It Matters for Peptide Purity (deep dive into chromatographic methods), Peptide Purity Standards: What Percentage Is Acceptable? (threshold guidance by application), Red Flags in Peptide Certificates of Analysis (fabricated CoA detection), and Third-Party Peptide Testing Labs: Janoshik & Others (lab-by-lab comparison). For the buyer verification framework, see How to Spot a Scam Peptide Shop and What to Look for in a Peptide Shop: A Buyer’s Checklist.

This article is for informational and educational purposes only and does not constitute medical advice. Research peptides are not approved for human consumption by the FDA or EMA. Always consult a qualified physician before using any peptide product. Peptigrity is an independent review platform with no financial relationship to any listed shop, manufacturer, or testing laboratory.